These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 21958873)
21. The recent updates of therapeutic approaches against aβ for the treatment of Alzheimer's disease. Ling S; Zhou J; Rudd JA; Hu Z; Fang M Anat Rec (Hoboken); 2011 Aug; 294(8):1307-18. PubMed ID: 21717585 [TBL] [Abstract][Full Text] [Related]
22. Proteolytic processing of the Alzheimer's disease amyloid precursor protein in brain and platelets. Evin G; Zhu A; Holsinger RM; Masters CL; Li QX J Neurosci Res; 2003 Nov; 74(3):386-92. PubMed ID: 14598315 [TBL] [Abstract][Full Text] [Related]
23. Hydrogen sulfide reduces mRNA and protein levels of β-site amyloid precursor protein cleaving enzyme 1 in PC12 cells. Zhang H; Gao Y; Zhao F; Dai Z; Meng T; Tu S; Yan Y Neurochem Int; 2011 Feb; 58(2):169-75. PubMed ID: 21095213 [TBL] [Abstract][Full Text] [Related]
24. Thiamine deficiency increases β-secretase activity and accumulation of β-amyloid peptides. Zhang Q; Yang G; Li W; Fan Z; Sun A; Luo J; Ke ZJ Neurobiol Aging; 2011 Jan; 32(1):42-53. PubMed ID: 19233513 [TBL] [Abstract][Full Text] [Related]
25. Immunomodulation of AβPP processing alleviates amyloid-β-related pathology in Alzheimer's disease transgenic mice. Arbel-Ornath M; Becker M; Rabinovich-Toidman P; Gartner M; Solomon B J Alzheimers Dis; 2010; 22(2):469-82. PubMed ID: 20847413 [TBL] [Abstract][Full Text] [Related]
26. 4-O-methylhonokiol attenuated memory impairment through modulation of oxidative damage of enzymes involving amyloid-β generation and accumulation in a mouse model of Alzheimer's disease. Choi IS; Lee YJ; Choi DY; Lee YK; Lee YH; Kim KH; Kim YH; Jeon YH; Kim EH; Han SB; Jung JK; Yun YP; Oh KW; Hwang DY; Hong JT J Alzheimers Dis; 2011; 27(1):127-41. PubMed ID: 21799245 [TBL] [Abstract][Full Text] [Related]
27. Decrease in brain soluble amyloid precursor protein β (sAPPβ) in Alzheimer's disease cortex. Wu G; Sankaranarayanan S; Hsieh SH; Simon AJ; Savage MJ J Neurosci Res; 2011 Jun; 89(6):822-32. PubMed ID: 21433051 [TBL] [Abstract][Full Text] [Related]
28. Low-density lipoprotein receptor-related protein promotes amyloid precursor protein trafficking to lipid rafts in the endocytic pathway. Yoon IS; Chen E; Busse T; Repetto E; Lakshmana MK; Koo EH; Kang DE FASEB J; 2007 Sep; 21(11):2742-52. PubMed ID: 17463224 [TBL] [Abstract][Full Text] [Related]
29. The amyloid-β₄₂ proxy, amyloid-β(25-35), induces normal human cerebral astrocytes to produce amyloid-β₄₂. Dal Prà I; Whitfileld JF; Pacchiana R; Bonafini C; Talacchi A; Chakravarthy B; Armato U; Chiarini A J Alzheimers Dis; 2011; 24(2):335-47. PubMed ID: 21258151 [TBL] [Abstract][Full Text] [Related]
30. The proteins BACE1 and BACE2 and beta-secretase activity in normal and Alzheimer's disease brain. Stockley JH; O'Neill C Biochem Soc Trans; 2007 Jun; 35(Pt 3):574-6. PubMed ID: 17511655 [TBL] [Abstract][Full Text] [Related]
31. BACE2, as a novel APP theta-secretase, is not responsible for the pathogenesis of Alzheimer's disease in Down syndrome. Sun X; He G; Song W FASEB J; 2006 Jul; 20(9):1369-76. PubMed ID: 16816112 [TBL] [Abstract][Full Text] [Related]
32. BACE2, a beta -secretase homolog, cleaves at the beta site and within the amyloid-beta region of the amyloid-beta precursor protein. Farzan M; Schnitzler CE; Vasilieva N; Leung D; Choe H Proc Natl Acad Sci U S A; 2000 Aug; 97(17):9712-7. PubMed ID: 10931940 [TBL] [Abstract][Full Text] [Related]
33. Chronic Anatabine Treatment Reduces Alzheimer's Disease (AD)-Like Pathology and Improves Socio-Behavioral Deficits in a Transgenic Mouse Model of AD. Verma M; Beaulieu-Abdelahad D; Ait-Ghezala G; Li R; Crawford F; Mullan M; Paris D PLoS One; 2015; 10(5):e0128224. PubMed ID: 26010758 [TBL] [Abstract][Full Text] [Related]
34. Dynamin 1 regulates amyloid generation through modulation of BACE-1. Zhu L; Su M; Lucast L; Liu L; Netzer WJ; Gandy SE; Cai D PLoS One; 2012; 7(9):e45033. PubMed ID: 23024787 [TBL] [Abstract][Full Text] [Related]
35. M344 promotes nonamyloidogenic amyloid precursor protein processing while normalizing Alzheimer's disease genes and improving memory. Volmar CH; Salah-Uddin H; Janczura KJ; Halley P; Lambert G; Wodrich A; Manoah S; Patel NH; Sartor GC; Mehta N; Miles NTH; Desse S; Dorcius D; Cameron MD; Brothers SP; Wahlestedt C Proc Natl Acad Sci U S A; 2017 Oct; 114(43):E9135-E9144. PubMed ID: 29073110 [TBL] [Abstract][Full Text] [Related]
36. Chronic 5-HT4 receptor activation decreases Aβ production and deposition in hAPP/PS1 mice. Tesseur I; Pimenova AA; Lo AC; Ciesielska M; Lichtenthaler SF; De Maeyer JH; Schuurkes JA; D'Hooge R; De Strooper B Neurobiol Aging; 2013 Jul; 34(7):1779-89. PubMed ID: 23474291 [TBL] [Abstract][Full Text] [Related]
37. Dose-dependent inhibition of BACE-1 by the monoterpenoid 2,3,4,4-tetramethyl-5-methylenecyclopent-2-enone in cellular and mouse models of Alzheimer's disease. Videira R; Castanheira P; Grãos M; Resende R; Salgueiro L; Faro C; Cavaleiro C J Nat Prod; 2014 Jun; 77(6):1275-9. PubMed ID: 24921156 [TBL] [Abstract][Full Text] [Related]
39. Elevation of BACE in an Aβ rat model of Alzheimer's disease: exacerbation by chronic stress and prevention by nicotine. Alkadhi KA; Alzoubi KH; Srivareerat M; Tran TT Int J Neuropsychopharmacol; 2012 Mar; 15(2):223-33. PubMed ID: 21356140 [TBL] [Abstract][Full Text] [Related]
40. BACE inhibition-dependent repair of Alzheimer's pathophysiology. Keskin AD; Kekuš M; Adelsberger H; Neumann U; Shimshek DR; Song B; Zott B; Peng T; Förstl H; Staufenbiel M; Nelken I; Sakmann B; Konnerth A; Busche MA Proc Natl Acad Sci U S A; 2017 Aug; 114(32):8631-8636. PubMed ID: 28739891 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]